Shenzhen New Industries Biomedical Engineering Co. Ltd. Class ASZSE: 300832

Shenzhen New Industries Biomedical Engineering Co: Q3 revenue and profit rose double digits year-over-year, driven by strong product and market growth

· Issued by Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

Q3 2024 revenue rose 15.38% and net profit grew 10.02% year-over-year, with strong gains in both domestic and overseas markets. New products showed robust market acceptance, while cash flow and asset growth remained solid.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

All Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A news releases